Cargando…

The State of the Dopaminergic and Glutamatergic Systems in the Valproic Acid Mouse Model of Autism Spectrum Disorder

Autism Spectrum Disorder (ASD) is a progressive neurodevelopmental disorder mainly characterized by deficits in social communication and stereotyped behaviors and interests. Here, we aimed to investigate the state of several key players in the dopamine and glutamate neurotransmission systems in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maisterrena, Alexandre, Matas, Emmanuel, Mirfendereski, Helene, Balbous, Anais, Marchand, Sandrine, Jaber, Mohamed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688008/ https://www.ncbi.nlm.nih.gov/pubmed/36421705 http://dx.doi.org/10.3390/biom12111691

Ejemplares similares

Major motor and gait deficits with sexual dimorphism in a Shank3 mutant mouse model
por: Matas, Emmanuel, et al.
Publicado: (2021)

Motor Impairments Correlate with Social Deficits and Restricted Neuronal Loss in an Environmental Model of Autism
por: Al Sagheer, Tareq, et al.
Publicado: (2018)

Sex-dependent behavioral deficits and neuropathology in a maternal immune activation model of autism
por: Haida, Obelia, et al.
Publicado: (2019)

Cerebellar and Striatal Implications in Autism Spectrum Disorders: From Clinical Observations to Animal Models
por: Thabault, Mathieu, et al.
Publicado: (2022)

Autism Spectrum Disorder: Focus on Glutamatergic Neurotransmission
por: Montanari, Martina, et al.
Publicado: (2022)

Potentiation of Glutamatergic Synaptic Transmission Onto Dorsal Raphe Serotonergic Neurons in the Valproic Acid Model of Autism
por: Wang, Ruixiang, et al.
Publicado: (2018)

GABAergic/glutamatergic imbalance relative to excessive neuroinflammation in autism spectrum disorders
por: El-Ansary, Afaf, et al.
Publicado: (2014)

The Effect of Ceftriaxone in Valproic Acid-Induced Mouse Model of Autism
por: Gur, Gamze, et al.
Publicado: (2022)

Dopaminergic Dysregulation in Syndromic Autism Spectrum Disorders: Insights From Genetic Mouse Models
por: Kosillo, Polina, et al.
Publicado: (2021)

Towards a Reconceptualization of Striatal Interactions Between Glutamatergic and Dopaminergic Neurotransmission and Their Contribution to the Production of Movements
por: David, Hélène N
Publicado: (2009)

Photobiomodulation Attenuated Cognitive Dysfunction and Neuroinflammation in a Prenatal Valproic Acid-Induced Autism Spectrum Disorder Mouse Model
por: Kim, Ui-Jin, et al.
Publicado: (2022)

The Biology and Pathobiology of Glutamatergic, Cholinergic, and Dopaminergic Signaling in the Aging Brain
por: Gasiorowska, Anna, et al.
Publicado: (2021)

What We Have Learned about Autism Spectrum Disorder from Valproic Acid
por: Chomiak, Taylor, et al.
Publicado: (2013)

Abnormal Development of Glutamatergic Synapses Afferent to Dopaminergic Neurons of the Pink1(−/−) Mouse Model of Parkinson’s Disease
por: Pearlstein, Edouard, et al.
Publicado: (2016)

A proapoptotic effect of valproic acid on progenitors of embryonic stem cell-derived glutamatergic neurons
por: Fujiki, R, et al.
Publicado: (2013)

Dopaminergic and glutamatergic microdomains within a subset of rodent mesoaccumbens axons
por: Zhang, Shiliang, et al.
Publicado: (2015)

Next-generation antipsychotics- Trends and perspectives beyond dopaminergic and glutamatergic agents
por: Vasiliu, O., et al.
Publicado: (2023)

Pathophysiological Studies of Monoaminergic Neurotransmission Systems in Valproic Acid-Induced Model of Autism Spectrum Disorder
por: Kuo, Hsiao-Ying, et al.
Publicado: (2022)

Addictive drugs and plasticity of glutamatergic synapses on dopaminergic neurons: what have we learned from genetic mouse models?
por: Rodriguez Parkitna, Jan, et al.
Publicado: (2012)

Changes in Sensitivity of Reward and Motor Behavior to Dopaminergic, Glutamatergic, and Cholinergic Drugs in a Mouse Model of Fragile X Syndrome
por: Fish, Eric W., et al.
Publicado: (2013)

Cariprazine alleviates core behavioral deficits in the prenatal valproic acid exposure model of autism spectrum disorder
por: Román, Viktor, et al.
Publicado: (2021)

Pedunculopontine glutamatergic neurons control spike patterning in substantia nigra dopaminergic neurons
por: Galtieri, Daniel J, et al.
Publicado: (2017)

Mice prenatally exposed to valproic acid do not show autism-related disorders when fed with polyunsaturated fatty acid-enriched diets
por: Turpin, Valentine, et al.
Publicado: (2023)

The Antiepileptic Drug and Toxic Teratogen Valproic Acid Alters Microglia in an Environmental Mouse Model of Autism
por: Triyasakorn, Korawin, et al.
Publicado: (2022)

Exploring the Validity of Valproic Acid Animal Model of Autism
por: Mabunga, Darine Froy N., et al.
Publicado: (2015)

Candidate glutamatergic and dopaminergic pathway gene variants do not influence Huntington’s disease motor onset
por: Ramos, Eliana Marisa, et al.
Publicado: (2013)

In utero Exposure to Valproic-Acid Alters Circadian Organisation and Clock-Gene Expression: Implications for Autism Spectrum Disorders
por: Ferraro, Sarah, et al.
Publicado: (2021)

Alterations in Cerebellar Microtubule Cytoskeletal Network in a ValproicAcid-Induced Rat Model of Autism Spectrum Disorders
por: Gąssowska-Dobrowolska, Magdalena, et al.
Publicado: (2022)

Oral Supplementation with Maca Improves Social Recognition Deficits in the Valproic Acid Animal Model of Autism Spectrum Disorder
por: Fu, Pinyue, et al.
Publicado: (2023)

Glutamatergic synaptic currents of nigral dopaminergic neurons follow a postnatal developmental sequence
por: Pearlstein, Edouard, et al.
Publicado: (2015)

The Role of Glutamatergic and Dopaminergic Neurons in the Periaqueductal Gray/Dorsal Raphe: Separating Analgesia and Anxiety
por: Taylor, Norman E., et al.
Publicado: (2019)

Glix 13, a New Drug Acting on Glutamatergic Pathways in Children and Animal Models of Autism Spectrum Disorders
por: Santini, Annamaria Chiara, et al.
Publicado: (2014)

Glutamatergic Dysfunction and Synaptic Ultrastructural Alterations in Schizophrenia and Autism Spectrum Disorder: Evidence from Human and Rodent Studies
por: Eltokhi, Ahmed, et al.
Publicado: (2020)

Long-Lasting Changes in Glial Cells Isolated From Rats Subjected to the Valproic Acid Model of Autism Spectrum Disorder
por: Traetta, Marianela Evelyn, et al.
Publicado: (2021)

Ascorbic Acid Inhibits Development of Tolerance and Dependence to Opiates in Mice: Possible Glutamatergic or Dopaminergic Modulation
por: Kulkarni, S. K., et al.
Publicado: (2008)

Direct Glutamatergic Signaling From Midbrain Dopaminergic Neurons Onto Pyramidal Prefrontal Cortex Neurons
por: Pérez-López, José Luis, et al.
Publicado: (2018)

rTMS-Induced Changes in Glutamatergic and Dopaminergic Systems: Relevance to Cocaine and Methamphetamine Use Disorders
por: Moretti, Jessica, et al.
Publicado: (2020)

Neuroanatomical changes of ionotropic glutamatergic and GABAergic receptor densities in male mice modeling idiopathic and syndromic autism spectrum disorder
por: Nardi, Leonardo, et al.
Publicado: (2023)

Exposure to Valproic Acid Inhibits Chondrogenesis and Osteogenesis in Mid-Organogenesis Mouse Limbs
por: Paradis, France-Hélène, et al.
Publicado: (2013)

Role of Glutamatergic Excitotoxicity in Neuromyelitis Optica Spectrum Disorders
por: da Silva, Ana Paula Bornes, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_l5qqdlgg56vtd1q3hlp4ospkan